123 related articles for article (PubMed ID: 2666615)
1. Effects of the renin inhibitor H77 on angiotensin II, arterial pressure and cardiac function in conscious dogs: comparison with captopril.
Tree M; MacArthur K; Inglis G; Leckie B; Lever AF; Morton JJ; Szelke M
J Hypertens Suppl; 1989 Apr; 7(2):S51-5. PubMed ID: 2666615
[TBL] [Abstract][Full Text] [Related]
2. In vivo comparison of the renin inhibitor H77 with the angiotensin-converting enzyme inhibitor captopril.
Oldham AA; Arnstein MJ; Major JS; Clough DP
J Cardiovasc Pharmacol; 1984; 6(4):672-7. PubMed ID: 6206324
[TBL] [Abstract][Full Text] [Related]
3. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effect of renin inhibition and angiotensin-converting enzyme inhibition in ovine heart failure.
Fitzpatrick MA; Rademaker MT; Charles CJ; Yandle TG; Espiner EA; Ikram H; Nussberger J
J Cardiovasc Pharmacol; 1992 Feb; 19(2):169-75. PubMed ID: 1376784
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
6. Captopril improves postresuscitation hemodynamics protective against pulmonary embolism by activating the ACE2/Ang-(1-7)/Mas axis.
Xiao HL; Li CS; Zhao LX; Yang J; Tong N; An L; Liu QT
Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1159-1169. PubMed ID: 27449068
[TBL] [Abstract][Full Text] [Related]
7. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
[TBL] [Abstract][Full Text] [Related]
8. Systemic and renal haemodynamic effects of renin or angiotensin converting enzyme inhibition in non-human primates.
Pals DT; Ludens JH; DeGraaf GL
J Hypertens Suppl; 1989 Apr; 7(2):S43-6. PubMed ID: 2666613
[TBL] [Abstract][Full Text] [Related]
9. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
10. A transition-state analogue inhibitor of human renin (H.261): test in vitro and a comparison with captopril in the anaesthetized baboon.
Szelke M; Tree M; Leckie BJ; Jones DM; Atrash B; Beattie S; Donovan B; Hallett A; Hughes M; Lever AF
J Hypertens; 1985 Feb; 3(1):13-8. PubMed ID: 3889146
[TBL] [Abstract][Full Text] [Related]
11. Effect of infused captopril on blood pressure and the renin-angiotensin-aldosterone system in normal dogs subjected to varying sodium balance.
Morton JJ; Tree M; Casals-Stenzel J
Am J Cardiol; 1982 Apr; 49(6):1395-400. PubMed ID: 7041583
[TBL] [Abstract][Full Text] [Related]
12. Acute hemodynamic effects of drugs acting on the renin-angiotensin system in acute heart failure.
Nekooeian AA; Ogilvie RI; Zborowska-Sluis D
Can J Cardiol; 1995 Jan; 11(1):59-64. PubMed ID: 7850666
[TBL] [Abstract][Full Text] [Related]
13. Importance of endogenous angiotensin II in the cardiovascular responses to sympathetic stimulation in conscious rabbits.
Isaacson JS; Reid IA
Circ Res; 1990 Mar; 66(3):662-71. PubMed ID: 2407370
[TBL] [Abstract][Full Text] [Related]
14. Haemodynamic effects of captopril in hypertensive patients: comparison with saralasin.
Fagard R; Amery A; Lijnen P; Reybrouck T
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():131s-134s. PubMed ID: 396066
[TBL] [Abstract][Full Text] [Related]
15. Evidence that the acute hypotensive effect of captopril in dogs is not wholly explained by a reduction of plasma angiotensin II and its direct vasoconstrictor effect.
Tree M; Morton JJ
Clin Sci (Lond); 1980 Dec; 59(6):451-6. PubMed ID: 7002436
[TBL] [Abstract][Full Text] [Related]
16. The effect of captopril on blood pressure and angiotensins I, II and III in sodium-depleted dogs: problems associated with the measurement of angiotensin II after inhibition of converting enzyme.
Morton JJ; Tree M; Casals-Stenzel J
Clin Sci (Lond); 1980 Jun; 58(6):445-50. PubMed ID: 6253115
[TBL] [Abstract][Full Text] [Related]
17. Lack of correlation between the acute haemodynamic response to intravenous captopril and plasma concentrations of angiotensin II in patients with chronic cardiac failure.
Flapan AD; Shaw TR; Edwards CR; Rademaker M; Davies E; Williams BC
Eur J Clin Pharmacol; 1992; 43(1):1-5. PubMed ID: 1505601
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of the blood pressure lowering action of renin inhibition and comparison with angiotensin converting enzyme inhibition.
Blaine EH
J Hypertens Suppl; 1989 Apr; 7(2):S47-9. PubMed ID: 2666614
[TBL] [Abstract][Full Text] [Related]
19. Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.
McCaa RE
Prog Biochem Pharmacol; 1980; 17():29-35. PubMed ID: 7010367
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
Packer M; Lee WH; Medina N; Yushak M
J Am Coll Cardiol; 1985 Sep; 6(3):635-45. PubMed ID: 2993397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
